1.8.2016

Brexit and Dispute Resolution – How Can You Start Preparing Yourself Now?

The result of the referendum arranged in Britain was a surprise for many. Never before has a Member State withdrawn from the European Union and only a few have considered withdrawal to be a feasible option. Before 2009, the treaties of the EU did not even include any provisions concerning withdrawal.

For the time being, the biggest impact of the decision of Britain to leave the EU has been increasing uncertainty. No one knows how the relationship between Britain and the EU will evolve, and forthcoming negotiations are likely to take years. However, business operations will not simply stop and wait for the end results of the negotiations, which is why it is important to be prepared already now for Britain’s withdrawal from the EU, to the extent possible.

Common Rules at Stake

The EU’s legislation facilitates cooperation between the Member States’ courts on many occasions. EU regulations lay down the frameworks binding all Member States on the following questions, among other things:

Upon Britain’s withdrawal from the EU, the regulations specified above will not necessarily continue to be applicable to Britain. In addition, Britain’s national legislation is expected to be amended in any case as a result of the withdrawal. It is also unclear what the significance of the case law given during the EU membership will be in Britain after the withdrawal.

The prevailing uncertainty creates added challenges for dispute resolution as the time between the drafting of an agreement and the emergence of a dispute can be years, if not decades. In order to manage risks related to Brexit we recommend, for the time being, favouring arbitration and choosing the laws of Finland or another Member State as the law applied to the agreement.

Two Clauses You Can Use to Reduce Risks Related to Brexit

Latest references

We assisted Pharmaca Health Intelligence in its acquisition of Mediaattori Ltd’s PODIUM Connect® and PODIUM Visits businesses. Through the acquisition, Pharmaca Health Intelligence strengthens its extensive service offerings in medical information, data-driven management, and education for both healthcare and pharmaceutical companies. Pharmaca Health Intelligence is a pioneer in digital medical information and a reliable partner for wellbeing services counties, the private healthcare sector and pharmacies. The company invests in the development of technology and service solutions related to pharmaceutical information, also on an international scale.
Case published 5.12.2024
We advised Gasum Oy in its acquisition of 100% of the shares in Hærup Biogas ApS, which owns and operates a biogas plant in the northern part of mainland Denmark. This acquisition marks Gasum’s first biogas plant in Denmark, expanding its biogas production portfolio. Gasum’s strategic goal is to bring seven terawatt hours of renewable gas to the Nordic market yearly by 2027. The acquisition is one step towards achieving the strategic goal. Gasum is a Nordic gas sector and energy market expert. Gasum offers cleaner energy and energy market expert services for industry and for combined heat and power production as well as cleaner fuel solutions for road and maritime transport. The company helps its customers to reduce their own carbon footprint as well as that of their customers. 
Case published 3.12.2024
We are advising Helkama-Autokauppa Oy in the acquisition of the Škoda dealerships in Helsinki and Tampere from Hedin Automotive Finland. The transaction is subject to regulatory approval. Helkama-Autokauppa Oy operates as an independent dealer in the dealer network of Helkama-Auto Oy, the Finnish importer of Škoda cars, spare parts and accessories.
Case published 3.12.2024
We advised Huhtamaki Oyj in relation to a EUR 450 million sustainability-linked syndicated multi-currency revolving credit facility loan agreement (“RCF”) with a maturity of five years. The RCF refinances an existing EUR 400 million sustainability-linked syndicated revolving credit facility signed in January 2021 and will be used for general corporate purposes of the Group. The RCF has two one-year extension options at the discretion of the lenders. The Mandated Lead Arrangers and Bookrunners of the RCF are Citi, Nordea Bank Abp, Skandinaviska Enskilda Banken AB (publ), BNP Paribas, Commerzbank Aktiengesellschaft, Danske Bank A/S, DBS Bank Ltd., London Branch, J.P. Morgan SE, Landesbank Hessen-Thüringen Girozentrale, OP Corporate Bank plc, Raiffeisen Bank International AG and Standard Chartered Bank AG.
Case published 28.11.2024